Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm

Physiological Reports

Volumn 4, Issue 6, 2016, Pages 1-13

  Wakamatsu, Ayako ^a   Fukusumi, Yoshiyasu ^a   Hasegawa, Eriko ^a   Tomita, Masayuki ^a   Watanabe, Toru ^b   Narita, Ichiei ^a   Kawachi, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Calcineurin; Podocyte; Proteinuria; Slit diaphragm

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NEPHRIN; PPP3CA PROTEIN, HUMAN; TACROLIMUS;

ANIMAL; CELL JUNCTION; CELL LINE; CHEMICALLY INDUCED; CHILD; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE; NEPHROTIC SYNDROME; PATHOLOGY; PODOCYTE; PROTEIN TRANSPORT; PROTEINURIA; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; CALCINEURIN; CALCINEURIN INHIBITORS; CELL LINE; CHILD; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERCELLULAR JUNCTIONS; MALE; MEMBRANE PROTEINS; MICE; NEPHROTIC SYNDROME; PODOCYTES; PROTEIN TRANSPORT; PROTEINURIA; RATS, WISTAR; TACROLIMUS; TIME FACTORS;

EID: 84962090159     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12679     Document Type: Article

References (39)

1. Azzi, J. R., M. H. Sayegh, and S. G. Mallat. 2013. Calcineurin inhibitors: 40 years later, can't live without. J. Immunol. 191:5785-5791.
2. Bram, R. J., D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
3. Charbit, M., M. C. Gubler, M. Dechaux, M. F. Gagnadoux, J. P. Grunfeld, and P. Niaudet. 2007. Cyclosporin therapy in patients with Alport syndrome. Pediatr. Nephrol. 22:57-63.
4. Chen, D., B. Jefferson, S. J. Harvey, K. Zheng, C. J. Gartley, R. M. Jacobs, et al. 2003. Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model. J. Am. Soc. Nephrol. 14:690-698.
5. Faul, C., M. Donnelly, S. Merscher-Gomez, Y. H. Chang, S. Franz, J. Delfgaauw, et al. 2008. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14:931-938.
6. Fukusumi, Y., A. Wakamatsu, N. Takashima, E. Hasegawa, N. Miyauchi, M. Tomita, et al. 2015. SV2B is essential for the integrity of the glomerular filtration barrier. Lab. Invest. 95:534-545.
7. Han, G. D., H. Koike, T. Nakatsue, K. Suzuki, H. Yoneyama, S. Narumi, et al. 2003. IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis. J. Am. Soc. Nephrol. 14:3111-3126.
8. Hashimoto, T., T. Karasawa, A. Saito, N. Miyauchi, G. D. Han, K. Hayasaka, et al. 2007. Ephrin-B1 localizes at the slit diaphragm of the glomerular podocyte. Kidney Int. 72:954-964.
9. Huber, T. B., M. Schmidts, P. Gerke, B. Schermer, A. Zahn, B. Hartleben, et al. 2003. The carboxyl terminus of Neph family members binds to the PDZ domain protein zonula occludens-1. J. Biol. Chem. 278:13417-13421.
10. Ito, Y., H. Kawachi, Y. Morioka, T. Nakatsue, H. Koike, Y. Ikezumi, et al. 2002. Fractalkine expression and the recruitment of CX3CR1 + cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int. 61:2044-2057.
11. Kawachi, H., D. R. Abrahamson, P. L. St John, D. J. Goldstein, M. A. Shia, K. Matsui, et al. 1995. Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6. Am. J. Pathol. 147:823-833.
12. Kawachi, H., H. Kurihara, P. S. Topham, D. Brown, M. A. Shia, M. Orikasa, et al. 1997. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am. J. Physiol. 273:F984-F993.
13. Kawachi, H., H. Koike, H. Kurihara, E. Yaoita, M. Orikasa, M. A. Shia, et al. 2000. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int. 57:1949-1961.
14. Kawachi, H., H. Koike, and F. Shimizu. 2002. mAb 5-1-6 nephropathy and nephrin. Microsc. Res. Tech. 57:236-240.
15. Kawachi, H., H. Koike, H. Kurihara, T. Sakai, and F. Shimizu. 2003. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J. Am. Soc. Nephrol. 14:46-56.
16. Li, X., X. Zhang, X. Li, X. Wang, S. Wang, and J. Ding. 2014. Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state. Exp. Biol. Med. 239:922-936.
17. Liu, G., B. Kaw, J. Kurfis, S. Rahmanuddin, Y. S. Kanwar, and S. S. Chugh. 2003. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J. Clin. Invest. 112:209-221.
18. Miyauchi, N., A. Saito, T. Karasawa, Y. Harita, K. Suzuki, H. Koike, et al. 2006. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli. J. Am. Soc. Nephrol. 17:2748-2759.
19. Mundel, P., J. Reiser, A. Zuniga Mejia Borja, H. Pavenstadt, G. R. Davidson, W. Kriz, et al. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236:248-258.
20. Nakatsue, T., H. Koike, G. D. Han, K. Suzuki, N. Miyauchi, H. Yuan, et al. 2005. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int. 67:2239-2253.
21. Nijenhuis, T., A. J. Sloan, J. G. Hoenderop, J. Flesche, H. van Goor, A. D. Kistler, et al. 2011. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am. J. Pathol. 179:1719-1732.
22. O'Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci, and E. A. O'Neill. 1992. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357:692-694.
23. Orikasa, M., K. Matsui, T. Oite, and F. Shimizu. 1988. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J. Immunol. 141:807-814.
24. Otaki, Y., N. Miyauchi, M. Higa, A. Takada, T. Kuroda, F. Gejyo, et al. 2008. Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis. Am. J. Physiol. Renal. Physiol. 295:F1376-F1387.
25. Pavenstadt, H., W. Kriz, and M. Kretzler. 2003. Cell biology of the glomerular podocyte. Physiol. Rev. 83:253-307.
26. Rusnak, F., and P. Mertz. 2000. Calcineurin: form and function. Physiol. Rev. 80:1483-1521.
27. Saito, A., N. Miyauchi, T. Hashimoto, T. Karasawa, G. D. Han, M. Kayaba, et al. 2011. Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300:R340-R348.
28. Shalhoub, R. J. 1974. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556-560.
29. Sharma, R., M. Sharma, X. Ge, E. T. McCarthy, and V. J. Savin. 1996. Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP. Transplantation 62:1916-1920.
30. Shibasaki, F., U. Hallin, and H. Uchino. 2002. Calcineurin as a multifunctional regulator. J. Biochem. 131:1-15.
31. Simons, M., K. Schwarz, W. Kriz, A. Miettinen, J. Reiser, P. Mundel, et al. 2001. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am. J. Pathol. 159:1069-1077.
32. Soderberg, O., M. Gullberg, M. Jarvius, K. Ridderstrale, K. J. Leuchowius, J. Jarvius, et al. 2006. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3:995-1000.
33. Spurney, R. F. 2014. Non-immunologic actions of calcineurin inhibitors in proteinuric kidney diseases. Front. Endocrinol. 5:181.
34. Suzuki, K., G. D. Han, N. Miyauchi, T. Hashimoto, T. Nakatsue, Y. Fujioka, et al. 2007. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am. J. Pathol. 170:1841-1853.
35. Suzuki, K., Y. Fukusumi, M. Yamazaki, H. Kaneko, K. Tsuruga, H. Tanaka, et al. 2015. Alteration in the podoplanin-ezrin-cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome. Cell Tissue Res. 362:201-213.
36. Talmadge, R. J., J. S. Otis, M. R. Rittler, N. D. Garcia, S. R. Spencer, S. J. Lees, et al. 2004. Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol. 5:28.
37. Topham, P. S., H. Kawachi, S. A. Haydar, S. Chugh, T. A. Addona, K. B. Charron, et al. 1999. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J. Clin. Invest. 104:1559-1566.
38. Wang, Y., G. Jarad, P. Tripathi, M. Pan, J. Cunningham, D. R. Martin, et al. 2010. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J. Am. Soc. Nephrol. 21:1657-1666.
39. Yan, K., J. Khoshnoodi, V. Ruotsalainen, and K. Tryggvason. 2002. N-linked glycosylation is critical for the plasma membrane localization of nephrin. J. Am. Soc. Nephrol. 13:1385-1389.